Dasamaps Dasatinib 50mg

the dasamaps 50mg tablet comprises dasatinib 50mg, a medication prescribed commonly for the treatment of chronic myelocytic leukemia and acute lymphoblastic leukemia. it works by inhibiting the activity of an abnormal protein that drives cancer cell growth and multiplication. this action stops their progression. this tablet is also prescribed for the treatment of patients with leukemia who have failed to respond to other forms of treatment in the past.